To assess the mechanisms underlying AHCC-mediated suppression of intestinal polyp formation, we evaluated the downstream targets of NRF2, such as MCP-1, and IL-6 mRNA expression in the non-polyp (mucosa) and polyp part of the intestine was investigated (Fig. 4). This evidence concerns the gene IL6 and polyp.